Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008059 · ClinicalTrials.gov registry record · NA
Alfentanil: Simultaneous Testing Pilot
A NA study of Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01008059: Completed NA study of Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A, sponsored by Washington University School of Medicine.
NCT01008059 is a NA study of Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A that has completed, run by Washington University School of Medicine. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01008059, a NA study of Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.
Primary Outcome
AUC(0-inf)
Conditions Studied
Interventions
- DRUG Alfentanil
Study Locations (1)
Missouri
- Washington University/Barnes Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT01008059 record still lists
NCT01008059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A appearing as the primary indexed condition, and to 1 intervention - of which Alfentanil is the first listed.
NCT01008059 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01008059 about?
NCT01008059 is a clinical study titled "Alfentanil: Simultaneous Testing Pilot". To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.
What is the current status of trial NCT01008059?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2009-10. Estimated completion is 2016-09.
What conditions does trial NCT01008059 study?
This clinical trial studies the following conditions: Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A.
What interventions are being tested in trial NCT01008059?
The interventions under investigation include: Alfentanil (DRUG).
Who is sponsoring clinical trial NCT01008059?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01008059 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01008059's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia